The role of annexin II tetramer in the activation of plasminogen
- PMID: 9468544
- DOI: 10.1074/jbc.273.8.4790
The role of annexin II tetramer in the activation of plasminogen
Abstract
Annexin II tetramer (AIIt) is a major Ca2+-binding protein of endothelial cells which has been shown to exist on both the intracellular and extracellular surfaces of the plasma membrane. In this report, we demonstrate that AIIt stimulates the activation of plasminogen by facilitating the tissue plasminogen activator (t-PA)-dependent conversion of plasminogen to plasmin. Fluid-phase AIIt stimulated the rate of activation of [Glu]plasminogen about 341-fold compared with an approximate 6-fold stimulation by annexin II. AIIt bound to [Glu]plasminogen(S741C-fluorescein) with a Kd of 1. 26 +/- 0.04 microM (mean +/- S.D., n = 3) and this interaction resulted in a large conformational change in [Glu]plasminogen. Kinetic analysis established that AIIt produces a large increase of about 190-fold in the kcat, app and a small increase in the Km,app which resulted in a 90-fold increase in the catalytic efficiency (kcat/Km) of t-PA for [Glu]plasminogen. AIIt also stimulated the t-PA-dependent activation of [Lys]plasminogen about 28-fold. Furthermore, other annexins such as annexin I, V, or VI did not produce comparable activation of t-PA-dependent conversion of [Glu]plasminogen to plasmin. The stimulation of the activation of [Glu]plasminogen by AIIt was Ca2+-independent and inhibited by epsilon-aminocaproic acid. AIIt bound to human 293 cells potentiated t-PA-dependent plasminogen activation. AIIt that was bound to phospholipid vesicles or heparin also stimulated the activation of [Glu]plasminogen 5- or 11-fold, respectively. Furthermore, immunofluorescence labeling of nonpermeabilized HUVEC revealed a punctated distribution of AIIt subunits on the cell surface. These results therefore identify AIIt as a potent in vitro activator of plasminogen.
Similar articles
-
The p11 subunit of the annexin II tetramer plays a key role in the stimulation of t-PA-dependent plasminogen activation.Biochemistry. 1998 Dec 1;37(48):16958-66. doi: 10.1021/bi981713l. Biochemistry. 1998. PMID: 9836589
-
Regulation of plasmin activity by annexin II tetramer.Biochemistry. 2000 Feb 8;39(5):1021-8. doi: 10.1021/bi991411z. Biochemistry. 2000. PMID: 10653646
-
Phospholipid-associated annexin A2-S100A10 heterotetramer and its subunits: characterization of the interaction with tissue plasminogen activator, plasminogen, and plasmin.J Biol Chem. 2003 Jul 11;278(28):25577-84. doi: 10.1074/jbc.M301017200. Epub 2003 Apr 30. J Biol Chem. 2003. PMID: 12730231
-
Role of annexin II tetramer in plasminogen activation.Trends Cardiovasc Med. 1999 Apr-May;9(3-4):92-102. doi: 10.1016/s1050-1738(99)00012-2. Trends Cardiovasc Med. 1999. PMID: 10578524 Review.
-
S100A10, annexin A2, and annexin a2 heterotetramer as candidate plasminogen receptors.Front Biosci. 2005 Jan 1;10:300-25. doi: 10.2741/1529. Print 2005 Jan 1. Front Biosci. 2005. PMID: 15574370 Review.
Cited by
-
Anti-annexin II antibody is associated with thrombosis and/or pregnancy morbidity in antiphospholipid syndrome and systemic lupus erythematosus with thrombosis.Rheumatol Int. 2011 Jul;31(7):865-9. doi: 10.1007/s00296-010-1379-4. Epub 2010 Mar 13. Rheumatol Int. 2011. PMID: 20229030
-
Lysyl oxidase-like 4 promotes the invasiveness of triple-negative breast cancer cells by orchestrating the invasive machinery formed by annexin A2 and S100A11 on the cell surface.Front Oncol. 2024 Mar 26;14:1371342. doi: 10.3389/fonc.2024.1371342. eCollection 2024. Front Oncol. 2024. PMID: 38595825 Free PMC article.
-
Tissue plasminogen activator in murine exocrine pancreas cancer: selective expression in ductal tumors and contribution to cancer progression.Am J Pathol. 2004 Oct;165(4):1129-39. doi: 10.1016/S0002-9440(10)63374-3. Am J Pathol. 2004. PMID: 15466380 Free PMC article.
-
Annexin A2-S100A10 heterotetramer is upregulated by PML/RARα fusion protein and promotes plasminogen-dependent fibrinolysis and matrix invasion in acute promyelocytic leukemia.Front Med. 2017 Sep;11(3):410-422. doi: 10.1007/s11684-017-0527-6. Epub 2017 Jul 8. Front Med. 2017. PMID: 28687976
-
S100A10 Has a Critical Regulatory Function in Mammary Tumor Growth and Metastasis: Insights Using MMTV-PyMT Oncomice and Clinical Patient Sample Analysis.Cancers (Basel). 2020 Dec 7;12(12):3673. doi: 10.3390/cancers12123673. Cancers (Basel). 2020. PMID: 33297495 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous